Recce Pharmaceuticals Ltd

RECEF · OTC
Analyze with AI
6/30/2025
6/30/2024
6/30/2023
6/30/2022
Operating Activities
Net Income$0-$18-$13-$11
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0-$0
Stock-Based Comp.$0$0$0$0
Change in WC-$0$4-$0$2
Other Non-Cash-$20$0-$0$0
Operating Cash Flow-$20-$13-$13-$9
Investing Activities
PP&E Inv.-$0-$0-$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases-$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.-$0$0$0$0
Investing Cash Flow-$0-$0-$0-$0
Financing Activities
Debt Repay.$1$6$3$0
Stock Issued$28$11$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$2-$1-$0-$1
Financing Cash Flow$27$16$3-$0
Forex Effect$0$0$0$0
Net Chg. in Cash$6$3-$10-$9
Supplemental Information
Beg. Cash$4$2$12$21
End Cash$10$4$2$12
Free Cash Flow-$20-$13-$13-$9